ALS Invest 1 B.V. - 06 Jul 2022 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
10%+ Owner
Signature
/s/ Felix-Andre von Coerper
Issuer symbol
AMLX
Transactions as of
06 Jul 2022
Net transactions value
-$1,254,642
Form type
4
Filing time
08 Jul 2022, 18:44:37 UTC
Previous filing
05 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMLX Common Stock Sale $357,816 -18,312 -0.31% $19.54 5,937,577 06 Jul 2022 Direct F1, F2
transaction AMLX Common Stock Sale $214,137 -10,395 -0.18% $20.60 5,927,182 06 Jul 2022 Direct F2, F3
transaction AMLX Common Stock Sale $630,965 -29,595 -0.5% $21.32 5,897,587 06 Jul 2022 Direct F2, F4
transaction AMLX Common Stock Sale $51,723 -2,307 -0.04% $22.42 5,895,280 06 Jul 2022 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

ALS Invest 1 B.V. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.975, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4) and (5) to this Form 4.
F2 The Reporting Person is managed by SUNU Ventures BV. Felix-Andre von Coerper is the sole corporate director of SUNU Ventures BV and has voting and dispositive power with respect to the securities held by the Reporting Person.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.99, inclusive.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.00 to $21.73, inclusive.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.03 to $22.655, inclusive.